BioSpace News Archive

Press Releases

Johnson & Johnson submits application to the European Medicines Agency seeking indication extension of AKEEGA® (niraparib and abiraterone acetate dual action tablet) for the treatment of adult patients with metastatic hormone-sensitive prostate cancer and HRR gene alterations

July 4, 2025
·
9 min read
Press Releases

Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico

July 4, 2025
·
5 min read
Press Releases

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 3, 2025

July 4, 2025
·
2 min read
Press Releases

INOVIO Announces Pricing of $25 Million Public Offering

July 4, 2025
·
5 min read
Press Releases

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 3, 2025

July 4, 2025
·
1 min read
Press Releases

InnoCare Announces Approval of Clinical Trial of a Novel ADC ICP-B794 in China

July 4, 2025
·
3 min read
Press Releases

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer

July 4, 2025
·
8 min read
Press Releases

Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessa’s Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist

July 4, 2025
·
3 min read
Press Releases

Orion publishes Half-Year Financial Report for January–June 2025 and holds a webcast on 18 July 2025

July 4, 2025
·
1 min read